NCT06595784

The HELlenic Thoracic Society Initiative for CΟPD and CVD

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 900 (estimated)
• Sponsor: Hellenic Thoracic Society · Academic / Other
• Sex: All
• Age: 35 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

COPD is one of the most common respiratory diseases in Greece, and maybe more than half a million Greek citizens suffer both from COPD and CVD, however their characteristics and management remain unknown. HELICOPD is a national, multicenter, prospective, non-interventional study designed to contribute to better understanding and depicting the demographic and clinical characteristics of this population, the COPD- and CVD-related adverse events in a two-years period, their quality of life and the healthcare resources use. The study is initiated and coordinated by the Hellenic Thoracic Society.

Conditions

• Chronic Obstructive Pulmonary Disease (COPD)
• Cardiovascular Diseases (CVD)

Timeline

• Start date: 2024-10-15
• Primary completion: 2026-10-01
• Completion: 2026-10-01
• First posted: 2024-09-19
• Last updated: 2025-09-10

Locations

2 sites across 1 country: Greece